Abstract
The role of auto-paracrine regulation of cell proliferation in breast cancer is analyzed. Experimental data indicate that the epidermal growth factor receptor is the key transmitter of mitogenic signals from the polypeptide growth factors and participates in the formation of sensitivity and/or resistance of breast cancer cells to steroid hormones. Data of representative clinical studies indicate that the expression of the epidermal growth factor receptor is prognostically unfavorable in breast cancer. Screening of patients with breast tumors for this receptor will detect the high-risk group at early stages of the disease. A scheme of the screening is proposed.
Similar content being viewed by others
References
E. S. Gershtein, L. S. Bassalyk, and V. P. Letyagin,Vopr. Onkol.,40, Nos. 7-12, 266–272 (1994).
E. S. Gershtein, V. D. Ermilova, Z. V. Kuz'mina,et al., Vestn. Rossiisk. Akad. Med. Nauk., No. 3, 15–19 (1996).
E. S. Gershtein, E. A. Kozyreva, Z. V. Kuz'mina,et al., Vestn. Onkol. Nauch. Tsentra Rossisk. Akad. Med. Nauk., No. 1, 22–26 (1994).
E. S. Gershtein, O. I. Kostyleva, and N. E. Kushlinskii,, No. 2, 51–59 (1995).
N. E. Kushlinskii, and E. S. Gershtein,Klin. Lab. Diagn., No. 1, 9–12 (1996).
N. E. Kushlinskii, and E. S. Gershtein,Mammologiya, No. 3, 15–25 (1996).
N. E. Kushlinskii, and E. S. Gershtein,Eksp. Klin. Farmakol., No. 1, 74–80 (1996).
N. E. Kushlinskii, E. S. Gershtein, V. A. Shatskaya,et al., Vestn. Onkol. Nauch. Tsentra Rossisk. Akad. Med. Nauk, No. 1, 17–22 (1994).
S. R. Ahmed, B. Badger, C. Wright,et al., J. Steroid Biochem. Mol. Biol.,38, 687–693 (1991).
D. K. Armstrong, S. H. Kaufmann, Y. L. Ottaviano,et al., Cancer Res.,54, 5280–5283 (1994).
C. L. Arteaga, and C. K. Osborne,Cancer Treat. Res.,53, 289–304 (1991).
J. A. Barnard, D. R. Graves, M. R. Pittelkow,et al., J. Biol. Chem.,269, 22822–22827 (1994).
S. E. Bates, N. E. Davidson, E. M. Valverius,et al., Mol. Endocrinol.,2, 543–555 (1988).
T. J. Benraad, and J. A. Foekens,Ann. Clin. Biochem.,27, 272–273 (1990).
Y. Berthois, X. F. Dong, and P. M. Martin,Biochem. Biophys. Res. Commun.,159, 126–131 (1989).
M. Bolla, M. Chedin, M. Colonna,et al., Breast Cancer Res. Treat.,29, 265–270 (1994).
A. W. Burgess, and C. M. Thumwood,Pathology,26, 453–463 (1994).
R. Castellani, D. W. Visscher, S. Wykes,et al., Cancer,73, 344–349 (1994).
C. Charpin, B. Devictor, P. Bonnier,et al., Breast Cancer Res. Treat.,25, 203–210 (1993).
S. A. Chrysogelos and R. B. Dickson,,29, 29–40 (1994).
F. Ciardiello, N. Kim, M. L. McGeady,et al., Ann. Oncol.,2, 169–182 (1991).
F. Ciardiello, M. L. McGeady, N. Kim,et al., Cell Growth Differ.,1, 407–420 (1990).
A. Ciccodicolo, R. Dono, S. Obici,et al., EMBO J.,8, 1987–1991 (1989).
R. C. Coombes, P. Barrett-Lee, and Y. Luqmani,J. Steroid Biochem. Mol. Biol.,37, 833–837 (1990).
E. M. Cormier, M. F. Wolf, and V. C. Jordan,Cancer Res.,49, 576–580 (1989).
S. Costa, H. Stamm, A. Almendral,et al., Lancet,2, 1258–1260 (1988).
P. de Cremoux, C. Gauville, and V. Closson,Int. J. Cancer,59, 408–415 (1994).
K. J. Cullen, H. S. Smith, S. Hill,et al., Cancer Res.,51, 4978–4985 (1991).
R. J. Daly, M. D. Binder, and R. L. Sutherland,Oncogene,9, 2723–2727 (1994).
N. E. Davidson, M. E. Gelmann, M. E. Lippman,et al., Mol. Endocrinol.,3, 372–380 (1989).
R. Dittadi, P. M. Donisi, A. Brazzale,et al., Brit. J. Cancer,67, 7–9 (1993).
W. C. Dougall, X. Qian, N. C. Peterson,et al., Oncogene,9, 2109–2123 (1994).
B. W. Ennis, E. M. Valverius, S. E. Bates,et al., Mol. Endocrinol.,3, 1830–1838 (1989).
S. L. Fitzpatrick, J. Brightwell, and J. L. Wittliff,Cancer Res.,44, 3448–3453 (1984).
J. A. Foekens, H. Portengen, M. Jansen,et al., Cancer,63, 2139–2147 (1989).
J. A. Foekens, H. Portengen, W. L. J. van Putten,et al., Cancer Res.,49, 7002–7009 (1989).
S. B. Fox, R. D. Leek, K. Smith,et al., Breast Cancer Res. Treat.,29, 109–116, (1994).
S. B. Fox, K. Smith, J. Hollyer,et al.,, 41–49.
G. Gasparini, P. Boracchi, P. Bevilacqua,et al.,, 59–61.
E. Gershtein, N. Kushlinsky, V. Ermilova,et al., Scand. J. Clin. Lab. Invest., Suppl., 55, No. 233, 406 (1995).
E. S. Gershtein, V. D. Ermilova, Z. V. Kuzmina,et al., Int. J. Oncol.,5, Suppl., 370 (1994).
E. S. Gershtein, R. E. Leake, N. E. Kushlinsky,et al., Eur. J. Cancer,30A, Suppl. 2, S43 (1994).
E. S. Geshtein, V. A. Shatskaya, O. I. Kostyleva,et al., Cancer,76, 2524–2529 (1995).
M. Grimaux, S. Romain, Y. Remvikos,et al., Breast Cancer Res. Treat.,14, 77–90 (1989).
A. L. Harris, S. Nicholson, R. Sainsbury,et al., J. Natl. Cancer Inst. Monogr.,11, 181–187 (1992).
J. J. Hsuan,Anticancer Res.,13, 2521–2532 (1993).
H. Iwase, S. Kobayashi, Y. Itoh,et al., Breast Cancer Res. Treat.,28, 215–221 (1993).
J. G. Klijn, P. M. Berns, P. I. Schmitz,et al., Endocr. Rev.,14, 3–6 (1993).
J. G. Klijn, P. M. Berns, P. I. Schmitz,et al.,,13, 3–17 (1992).
J. G. Klijn, M. P. Look, H. Portengen,et al., Breast Cancer Res. Treat.,29, 73–83 (1994).
P. G. Koenders, L. V. Beex, C. B. Kienhuis,et al.,,25, 21–27 (1993).
R. D. Leek, L. Kaklamanis, F. Pezzella,et al., Brit. J. Cancer.,69, 135–139 (1994).
S. LeJeune, R. Leck, E. Horak,et al., Cancer Res.,53, 3597–3602 (1993).
M. A. Lemmon, and J. Schlessinger,Trends Biochem. Sci.,19, 459–463 (1994).
B. S. Leung, L. Stout, L. Zhou,et al., J. Cell. Biochem.,46, 125–133 (1991).
S. Lewis, A. Locker, J. H. Todd,et al., J. Clin. Pathol.,43, 358–390 (1990).
D. K. Lutrell, A. Lee, T. J. Lansing,et al., Proc. Natl. Acad. Sci. USA,91, 83–87 (1994).
M. Martinazzi, F. Crivelli, C. Zampatti,et al., Pathologica,85, 637–644 (1993).
H. Mueller, P. Loop, K. Wosikowski,et al., Eur. J. Biochem.,22, 631–637 (1994).
L. C. Murphy, and H. Dotzlaw,Cancer Res.,49, 599–604 (1989).
A. Nesterov, R. C. Kurten, and G. N. Gill,J. Biol. Chem.,270, 6320–6327 (1995).
A. Nesterov, S. Lysan, I. Vdovina,et al., Arch. Biochem. Biophys.,313, 351–359 (1994).
R. I. Nicholson, J. M. W. Gee, A. B. Francis,et al., Endocrine-Related Cancer,2, 115–121 (1995).
R. I. Nicholson, R. A. McClelland, J. M. Gee,et al., Breast Cancer Res. Treat.,29, 117–125 (1994).
R. I. Nicholson, R. A. McClelland, P. Finlay,et al., Eur. J. Cancer,29A, 1018–1023 (1993).
R. I. Nicholson, P. Halcrow, J. R. Sainsbury,et al., Brit. J. Cancer,58, 810–814 (1988).
R. I. Nicholson, J. R. Sainsbury, P. Halcrow,et al., Lancet,1, No. 8631, 182–185 (1989).
N. Normanno, F. Ciardiello, R. Brandt,et al., Breast Cancer Res. Treat.,29, 11–27 (1994).
L. K. Opresko, C. Chang, B. H. Will,et al., J. Biol. Chem.,270, 4325–4333 (1995).
M. J. Railo, K. V. Smitten, and F. Pekonen,Acta Oncol.,33, 13–17 (1994).
M. A. Rios, A. Macias, R. Perez,et al., Anticancer Res.,8, 173–176 (1988).
T. Saeki, A. Cristiano, M. J. Lynch,et al., Mol. Endocrinol.,5, 1955–1963 (1991).
D. S. Salomon, W. R. Kidwell, N. Kim,et al., Recent Results Cancer Res.,113, 57–69 (1989).
R. Sauer, A. Schauer, H. F. Rauschecker,et al., Strahlenther. Onkol.,168, 191–202 (1992).
J. Schlessinger,Biochemistry,27, 3119–3123 (1988).
A. K. Sharma, K. Horgan, A. Douglas-Jones,et al., Brit. J. Cancer,69, 1032–1037 (1994).
A. K. Sharma, K. Horgan, R. A. McClelland,et al., Histochem. J.,26, 306–310 (1994).
M. S. Sheikh, Z. M. Shao, J. C. Chen,et al., J. Cell. Biochem.,54, 289–298 (1994).
E. Skasko, Z. Paszko, B. Bielinska,et al., Tumori,80, 56–60 (1994).
R. Spaventi, E. Kamenjicki, N. Pecina,et al., In Vivo,8, 183–189 (1994).
F. Spyratos, J.-C. Delarue, C. Andrieu,et al., Breast Cancer Res. Treat.,17, 83–88 (1990).
F. Spyratos, P. M. Martin, K. Hacene,et al.,,29, 85–95 (1994).
R. K. Sweeb and J. H. Beinjen,Pharm. World. Sci.,15, 233–242 (1993).
M. Toi, T. Tominaga, A. Osaki,et al., Breast Cancer Res. Treat.,29, 51–58 (1994).
Y. Umekita, N. Enokizono, Y. Sagara,et al., Virchows Arch.,420, 345–351 (1992).
T. van Agthoven, Th. L. van Agthoven, H. Portengen,et al., Cancer Res.,52, 5082–5088 (1992).
C. P. van Roozendaal, B. van Ooijen, J. G. M. Klijn,et al., Brit. J. Cancer.,65, 77–81 (1992).
D. W. Vischer, R. Castellani, S. M. Wykes,et al., Breast Cancer Res. Treat.,28, 261–266 (1993).
R. A. Walker and J. M. Varley,Cancer Surv.,16, 31–57 (1993).
K. Wosikowski, W. Kung, M. Hasmann,et al., Int. J. Cancer,53, 290–297 (1993).
R. Zeillinger, F. Kury, P. Speiser,et al., Clin. Biochem.,26, 221–227 (1993).
Author information
Authors and Affiliations
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 126, No. 11, pp. 485–496, November, 1998
Rights and permissions
About this article
Cite this article
Kushlinskii, N.E., Gershtein, E.S. Epidermal growth factor receptors in breast cancer: from experiment to clinical practice. Bull Exp Biol Med 126, 1073–1082 (1998). https://doi.org/10.1007/BF02447238
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02447238